Know Cancer

or
forgot password

A CROSS-SECTIONAL STUDY OF PATIENT-REPORTED OUTCOMES FOR BLADDER CANCER PATIENTS WITH NON-INVASIVE DISEASE


N/A
18 Years
N/A
Not Enrolling
Both
Bladder Cancer

Thank you

Trial Information

A CROSS-SECTIONAL STUDY OF PATIENT-REPORTED OUTCOMES FOR BLADDER CANCER PATIENTS WITH NON-INVASIVE DISEASE


OBJECTIVES:

- To identify aspects of survivorship experience that differ by clinical risk (low risk
vs high risk) in patients with non-invasive bladder cancer.

- To collect and examine data on health-related quality of life (HRQOL) and symptom
management.

- To analyze differences in outcomes between genders, stage and grade of disease, and
recency of diagnosis (new diagnosis vs ≥ 6 month diagnosis).

OUTLINE: Patients undergo a 45-minute telephone interview to assess their current medical
condition and psychological functioning (i.e., bladder cancer treatment history, levels of
depression and anxiety, quality of life, self-efficacy, and perceived social support).
Patients complete a series of questionnaires including the Lepore social constraint measure;
REACH social support measure; self-report inventories assessing patient communication,
relationship style, illness intrusiveness, fear of recurrence, and social constraint; Impact
of Events scale; Brief Symptom Index-18 and Global Severity Index; EORTC QLQ-C30 (general
health-related quality of life); and EORTC QLC-BLS24 (disease-specific health-related
quality of life).

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of non-invasive bladder cancer within the past 4 years

PATIENT CHARACTERISTICS:

- Not pregnant

- Able to read, speak, and understand English

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Outcome Measure:

Collection and examination of data on health-related quality of life and symptom management

Outcome Time Frame:

Cross-sectional

Safety Issue:

No

Principal Investigator

David M. Latini, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baylor College of Medicine

Authority:

United States: Federal Government

Study ID:

CDR0000600461

NCT ID:

NCT00744744

Start Date:

May 2008

Completion Date:

July 2011

Related Keywords:

  • Bladder Cancer
  • stage 0 bladder cancer
  • Urinary Bladder Neoplasms

Name

Location

Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas  77030